We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.60 | 9.40 | 9.80 | 9.60 | 9.60 | 9.60 | 114,837 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.44 | 89.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/10/2018 11:22 | "70,385 @ 10.22 will have the TrHYPErs shouting FOOL," . Not long ago, I posted about 'the possibility' of someone trading 75,000 /76,000 shares, Making / Taking a PROFIT of circa £350 in a couple of hours. This 'idea' was met by the usual derision - by the usual suspects / trHYPE lovers - as to 'how pathetic' a PROFIT of circa £350 is/would be. However IF the same trade { a sell of 76,000} was placed today - The 'punt' would be worth £1,577 LESS A PROFIT of circa £350... now = A LOSS of £1,577 on the SAME figs. A difference / TOTAL amount of cash 'thrown away' of....£1,927 . Add this thought to the recent trades by Rhatton, which saw a gain on today's S P of £3,600 { 240,000 ish sold at 11.6p ..now selling at 10.10p} , Just to put a little 'Alternative View' into perspective- The CLUB buy, buy, buy of 55,500 at 44,6p ish = circa £25,000 NOW worth = circa £5,600 AND THEY rubbish a PROFIT of £350... or ...A 'GAIN' of circa £3,600 . One might ask = WHO / WHY - are the 'underwater' FOOLS here ??? | the real lozan | |
08/10/2018 10:29 | 70,385 @ 10.22 will have the TrHYPErs shouting FOOL, only to see that trader buy back in at 7.22p following the next open offer. | terror | |
05/10/2018 14:21 | I ask again - Do *WE ALL* think Rhatton was 'UNWISE' to 'observe/act'...by SELLING out circa 240,000 shares at 11.60p ... and NOT just "ride a silly market behaviour"... as the prince of FAILED / SUPERIOR / PRIVALAGED trHYPERS /swallowers was advocateing ??? OR Was Rhatton RIGHT ??? | the real lozan | |
05/10/2018 13:12 | Sub 10p on the cards? | wanderer1210_0 | |
05/10/2018 13:08 | Putting REALITY and {my} 'Alternative Views' into 'perspective' - If *WE ALL* cast our minds back to the days { 6/7 years ago} to the times of the in-famous " £1 a share today On the CARDS " and ongoing trHYPE... let us see ??? Many many moons ago,I asked -"What is the difference between inanecur and BIGFOOT ???" In those 6/7 years of FAILURE, How much has the 'value' of trHYPE swallowers investment - gone DOWN ??? Alternative - In those 6/7 years of FAILURE,By How much have investors 'Council Tax' gone UP ??? Not only have the swallowers of the BUY,BUY,BUY and HOLD SCAM...LOST on their 'investment'...BUT, they have 'fallen behind' in other ways. What HAS NOT gone DOWN..is the 'dwindled' trHYPERS / swallowers arrogant self belief, that they feel themselves to be more knowledgeable, better informed,simply SUPERIOR than anyone, who spots the chances to have Made and Taken PROFITS.. whilst -due to following 'der leader'...the 'SUPERIOR' trHYPERS/swallowers sank DEEPER 'underwater'. The REALITY of the situation is not just the LOSSES in ivestment 'value' This must be added to the amount that 'DEAD money' has 'fallen in value' {cost of NOT living} Some of *US* Wiser, more ASTUTE folks just got on with *OUR* lives, Making and Taking PROFITS along the way...Without the NEED to FEEL 'SUPERIOR' in any way to those trHYPERS / swallowers 'GROUP'... who appear to think themselves 'PRIVALAGED'. . Just MY 'Alternative Outlook on LIFE' as 10p appears in the S P 'window'. . For those not around when I asked - "What is the difference between inanecur and BIGFOOT' ???....My comment at the time was = "Encountering a BIGFOOT.. may NOT cost you 'An arm and a leg" | the real lozan | |
04/10/2018 13:00 | Alas no tweets of abstracts B104 Katherine Cook, B102 Victoria Brentville & A161 Mireille Vankemmelbeke presenting. | gooosed | |
04/10/2018 12:55 | Agree Loz The SCAMaco expert is wrong again and he must be another 10000 smackers underwater. He must be drowning in misery which is why he is quiet. Why does he just admit he is Wtong but his EGO always wins. What do they say about Fools and their money.Well there is your PROOF | drdobson1 | |
04/10/2018 10:38 | Why 'Alternative Views' 'MATTER' - Just about one week ago, SCAMACO and the'few', took it upon themselves to scornfully belittle Rhatton for selling at 11.6p.... obviously = An 'effort' to 'dissuade the sheeple from taking similar action' AWAY from the BUY,BUY,BUY and HOLD...costly trHYPE SCAM. The REALITY IS = Rhatton sold circa 240,000 at 11.6p.... Against the 'dictates of *the expert* Rhatton, at today's S P { 10.22p to sell}...'Benefits' by circa £3,250 SO - Was Rhatton RIGHT to ignore the trHYPE ??? | the real lozan | |
04/10/2018 09:00 | The share price decline continues on lack of news, cash burn increasing, no deals and generally a seasonal apathy. The Autumn season has never been good for Scancell and the 'Fall' will continue for some weeks yet. | terror | |
03/10/2018 21:56 | Well you can't report anything new if there ain't anything new can you. I did point out that historically the share price drops on publication of annual results. Not sure if anyone took any notice! | gazza | |
03/10/2018 17:30 | Indeed Gazza, and as predicted, the temporary rally in the share price a few weeks ago has been washed away because the annual statement contained nothing new, nor was it preceded by anything dynamic. | tosh123 | |
03/10/2018 17:06 | Tosh, not sure it's just the other place, this place is fairly quite as well. Of course, the other place is limited in what can and can't be said so perhaps a little quieter.Fact is, there isn't much to talk about as far as SCLP are concerned until trials start and data is published. Until then, nothing much is gonna happen share price wise anyway. It's very much the "lull" predicted by Loz and others. | gazza | |
03/10/2018 13:38 | Is it me, or has the other place now become a tumble weed site ? You dont think that they have actually killed the BB do you ? A self fulfilling prophecy if ever i've seen one. | tosh123 | |
03/10/2018 02:32 | Gazza 17889 - actually I agree with that and have often posted about the massive workload facing the tiny Scancell team and the difficulty of moving all the 'elephants' forward at the same time in an ever expanding front of science. OK Scancell have some great partners . . and at least SCIB2 has been 'farmed out' for now. Commercialising Immunobody would boost MCap and facilitate fastest advancing of Moditopes. And get the science to the Patients quicker . . . . I also see Gooosed's point about collaborations and would add that hanging onto ALL the science, might well lead to the greatest dividend, one day . . . but after the longest wait !! Never mind - let's see if BoD have summat up the sleeve. | torquayfan | |
02/10/2018 17:35 | Goosed, yes, an equally valid opinion. Time will tell.... | gazza | |
02/10/2018 14:20 | Gazza - or adds to a pipeline of IP that enhances the prospects of a commercial collaboration. | gooosed | |
02/10/2018 14:07 | And for me, Therein lies the problem. Commercialising one of the "older" technologies would probably yield better shareholder value than constantly being at the "bleeding edge". The double whammy is 1) it requires funding from scarce resources and 2) potentially renders existing technology obsolete. Anyone else feel the same? | gazza | |
02/10/2018 13:27 | tosh123 - from my very limited understanding Glycosylation is at very early stages of research. | gooosed | |
02/10/2018 13:26 | Tosh, That's a bit of a leap isn't it? Not sure how you can draw any conclusions from the fact that Roche have signed a tiny (pocket money by their standards) deal with GO. | bermudashorts | |
02/10/2018 13:14 | Good find Gooosed. Seems a shame though because i thought that RG had inferred that we were relatively close to Roche, and that they would be our preferred partner ( i could be wrong though ). If my memory serves me right and im correct with the above, it would suggest that they have looked at the data room, and decided to deal elsewhere ! | tosh123 | |
01/10/2018 19:01 | Goosey who is right on the argument on MFFF regarding whether this new development is a new platform or simply a modification for Moditope. In the blue corner you have well respected science poster Barmooda Shorties and in the PLUM coloured corner you have Failed Prof baNANA a known liar and EGOtist with a proven track record of stealing other scientists CONtributions and of Failed predictions I know who my money is on and it ain’t PLUM DUFF | drdobson1 | |
01/10/2018 17:43 | Moditope evolving - will be interesting to see what CRUK GC adds if project Blueprint is selected. In my opinion Nextlink there's too much under one platform for Scancell to develop on their own. If the current research collaboration with BioNTech produces interest (Q22019) then Scancell may well secure the chance to see Lindy's work taken to the next level. A few more years - maybe, maybe not but good luck. | gooosed | |
01/10/2018 13:59 | I keep a close eye just in case and sympathise with current investors. Sold out a few years ago and at the time had the concern I might miss a spectacular rise a few months later. I would never say I would not buy in again, as the company has considerable patented IP, which might or might not have considerable value at some point. From my perspective there is little to tempt me, it feels as if I have a few more years to consider investing, possibly at a much lower share price | nextlink |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions